China Cohort Study of Rheumatoid Arthritis

Not Applicable

Not yet recruiting

• Conditions: Rheumatoid arthritis

• Registration Number: ITMCTR2022000044
• Lead Sponsor: Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

?meet the 1987 American College of Rheumatology (ACR) revised classification criteria for RA; ?Chinese residents aged >18 years; and ?agree to sign the informed consent form.

Exclusion Criteria

?Patients with cognitive or other impairments (e.g., visual acuity, etc.) that affect the participant's ability to complete the self-report; ?Patients with severe combined diseases of vital organs such as cardiovascular, cerebral, hepatic, pulmonary, renal and hematopoietic systems, acute and chronic infectious diseases, malignancies, and psychiatric diseases; ?Patients with autoimmune diseases other than overlapping RA

Study & Design

• Study Type: Observational study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patient-based Clinical Reported Outcome Scale;

Secondary Outcome Measures

Name	Time	Method
HAQ scale;VAS scale;Rheumatoid arthritis Chinese medical evidence efficacy evaluation scale;Tongue image information;Indicators of inflammation in the acute phase;Mean disease activity score for 28 joints;